Workflow
Cabot (CBT)
icon
Search documents
Cabot's (CBT) Earnings Top Estimates in Q2, Revenues Lag
Zacks Investment Research· 2024-05-07 13:46
Cabot Corporation (CBT) recorded second-quarter fiscal 2024 (ending Mar 31, 2024) earnings of $1.49 per share, up from the year-ago quarter's $1.29.CBT posted adjusted earnings of $1.78 per share, up from the year-ago quarter figure of $1.33. It surpassed the Zacks Consensus Estimate of $1.66.The company’s net sales in the fiscal second quarter were $1,019 million, which missed the Zacks Consensus Estimate of $1,054.1 million. Net sales decreased around 1.4% from the prior-year quarter.Segment HighlightsRei ...
Cabot (CBT) Surpasses Q2 Earnings Estimates
Zacks Investment Research· 2024-05-06 23:21
Cabot (CBT) came out with quarterly earnings of $1.78 per share, beating the Zacks Consensus Estimate of $1.66 per share. This compares to earnings of $1.33 per share a year ago. These figures are adjusted for non-recurring items.This quarterly report represents an earnings surprise of 7.23%. A quarter ago, it was expected that this chemical company would post earnings of $1.49 per share when it actually produced earnings of $1.56, delivering a surprise of 4.70%.Over the last four quarters, the company has ...
Cabot (CBT) - 2024 Q2 - Quarterly Results
2024-05-06 20:48
Key Highlights Sean Keohane, Cabot President and Chief Executive Officer, commented on the quarter, "I am very pleased with our second quarter results, as the Cabot team continued to execute against our Creating for Tomorrow strategy by delivering significant growth in Adjusted EPS year-over-year. Reinforcement Materials continued to demonstrate excellent performance, delivering EBIT of $149 million driven by price and product mix improvements in our calendar 2024 customer agreements and higher segment volu ...
Cabot (CBT) Chosen for $5M DOE Grant to Aid Hydrogen Economy
Zacks Investment Research· 2024-04-22 11:56
Cabot Corporation (CBT) stated that its application for a $5 million research grant has been selected by the United States Department of Energy ("DOE") under the Bipartisan Infrastructure Law. Cabot and its partners will utilize this money to help the implementation of fuel cells, which generate electricity by emitting only water.Fuel cells play a crucial role in the global transition to electric mobility, particularly in the electrification of long-distance transportation. This significance derives from th ...
Here's Why Cabot (CBT) is a Strong Value Stock
Zacks Investment Research· 2024-04-15 14:46
It doesn't matter your age or experience: taking full advantage of the stock market and investing with confidence are common goals for all investors. Luckily, Zacks Premium offers several different ways to do both.Featuring daily updates of the Zacks Rank and Zacks Industry Rank, full access to the Zacks #1 Rank List, Equity Research reports, and Premium stock screens, the research service can help you become a smarter, more self-assured investor.Zacks Premium includes access to the Zacks Style Scores as we ...
Cabot Corporation Launches New PROPEL® E8 Engineered Reinforcing Carbon Black for Tire Tread Applications
Businesswire· 2024-03-18 20:00
BOSTON--(BUSINESS WIRE)--Cabot Corporation (NYSE: CBT) today announced the global launch of its new PROPEL® E8 engineered reinforcing carbon black designed to provide superior tread durability at low rolling resistance for high-performance tire tread applications. This new product addresses the unique challenges posed by the heavier weight and higher torque of electric vehicles (EVs) compared to traditional internal combustion engine (ICE) vehicles. The PROPEL E8 grade complements Cabot’s existing solutions ...
Cabot (CBT) Up 11.4% Since Last Earnings Report: Can It Continue?
Zacks Investment Research· 2024-03-06 17:36
A month has gone by since the last earnings report for Cabot (CBT) . Shares have added about 11.4% in that time frame, outperforming the S&P 500.Will the recent positive trend continue leading up to its next earnings release, or is Cabot due for a pullback? Before we dive into how investors and analysts have reacted as of late, let's take a quick look at the most recent earnings report in order to get a better handle on the important drivers. Cabot's Earnings and Revenues Beat Estimates in Q1Cabot recorded ...
Why Cabot (CBT) is a Top Momentum Stock for the Long-Term
Zacks Investment Research· 2024-02-22 15:56
Taking full advantage of the stock market and investing with confidence are common goals for new and old investors, and Zacks Premium offers many different ways to do both.The popular research service can help you become a smarter, more self-assured investor, giving you access to daily updates of the Zacks Rank and Zacks Industry Rank, the Zacks #1 Rank List, Equity Research reports, and Premium stock screens.Zacks Premium includes access to the Zacks Style Scores as well.What are the Zacks Style Scores?The ...
Cabot (CBT) - 2024 Q1 - Quarterly Report
2024-02-07 16:00
[Part I. Financial Information](index=3&type=section&id=Part%20I.%20Financial%20Information) [Item 1. Financial Statements](index=3&type=section&id=Item%201.%20Financial%20Statements) This section presents the unaudited consolidated financial statements for the quarter ended December 31, 2023, showing a slight decrease in net sales, lower net income, and improved cash from operations Consolidated Statements of Operations (Unaudited) | Metric | Three Months Ended Dec 31, 2023 (in millions) | Three Months Ended Dec 31, 2022 (in millions) | | :--- | :--- | :--- | | Net sales and other operating revenues | $958 | $965 | | Gross profit | $218 | $181 | | Income from operations | $136 | $105 | | Net income attributable to Cabot Corporation | $50 | $54 | | Diluted Earnings per common share | $0.88 | $0.93 | Consolidated Balance Sheets Highlights (Unaudited) | Metric | December 31, 2023 (in millions) | September 30, 2023 (in millions) | | :--- | :--- | :--- | | Total current assets | $1,692 | $1,626 | | Total assets | $3,695 | $3,604 | | Total current liabilities | $830 | $822 | | Total stockholders' equity | $1,475 | $1,407 | | Total liabilities and stockholders' equity | $3,695 | $3,604 | Consolidated Statements of Cash Flows Highlights (Unaudited) | Metric | Three Months Ended Dec 31, 2023 (in millions) | Three Months Ended Dec 31, 2022 (in millions) | | :--- | :--- | :--- | | Cash provided by operating activities | $105 | $52 | | Cash used in investing activities | ($54) | ($17) | | Cash used in financing activities | ($29) | ($92) | | Increase (decrease) in cash | $6 | ($16) | [Notes to the Consolidated Financial Statements](index=10&type=section&id=Notes%20to%20the%20Consolidated%20Financial%20Statements) The notes detail accounting policies and financial items, including a **$40 million foreign exchange loss** in Argentina, **$9 million in restructuring charges**, and stable **$38 million reserve for respirator liabilities** - The company's Argentinian subsidiary recorded a significant **foreign exchange loss of $40 million** due to the revaluation of monetary balances, with **$33 million** resulting from a single devaluation action by the new government[41](index=41&type=chunk) - In Q1 fiscal 2024, the company initiated restructuring activities, including closing a reinforcing carbons unit in Tianjin, China, and temporarily idling an aerogel plant in Frankfurt, Germany. This resulted in **restructuring charges of $9 million** for the quarter[48](index=48&type=chunk)[65](index=65&type=chunk) - The **reserve for respirator-related liabilities**, a long-standing contingency, was unchanged at **$38 million** as of December 31, 2023, and September 30, 2023[61](index=61&type=chunk) Segment Revenues from External Customers (Q1 FY24 vs Q1 FY23) | Segment | Q1 2023 (in millions) | Q1 2022 (in millions) | | :--- | :--- | :--- | | Reinforcement Materials | $641 | $643 | | Performance Chemicals | $285 | $286 | | **Segment Total** | **$926** | **$929** | [Item 2. Management's Discussion and Analysis of Financial Condition and Results of Operations (MD&A)](index=19&type=section&id=Item%202.%20Management%27s%20Discussion%20and%20Analysis%20of%20Financial%20Condition%20and%20Results%20of%20Operations) Management's analysis indicates that while consolidated net sales slightly decreased year-over-year, gross profit increased by **$37 million** due to higher volumes and margins, with total segment EBIT growing by **$40 million** to **$163 million**, despite a **$40 million foreign currency loss** in Argentina, and cash from operations more than doubling to **$105 million** - **Consolidated gross profit increased by $37 million** YoY, primarily due to higher volumes and improved unit margins in both the Reinforcement Materials and Performance Chemicals segments[125](index=125&type=chunk) Segment EBIT Performance (Q1 FY24 vs Q1 FY23) | Segment | EBIT Q1 2024 (in millions) | EBIT Q1 2023 (in millions) | Change (in millions) | | :--- | :--- | :--- | :--- | | Reinforcement Materials | $129 | $94 | +$35 | | Performance Chemicals | $34 | $29 | +$5 | | **Total Segment EBIT** | **$163** | **$123** | **+$40** | - **Reinforcement Materials EBIT increased by $35 million** YoY, driven by higher unit margins (**$28 million**) from favorable pricing and product mix, and higher volumes (**$5 million**) in Europe and Asia[110](index=110&type=chunk) - **Other expense increased by $24 million** YoY, primarily due to **$40 million in foreign currency losses** from the Argentine peso devaluation, partially offset by **$12 million in investment income** in Argentina[78](index=78&type=chunk) - **Cash flow from operating activities increased significantly to $105 million** in Q1 2024 from **$52 million** in Q1 2023, mainly due to improved segment EBIT[115](index=115&type=chunk) [Item 3. Quantitative and Qualitative Disclosures About Market Risk](index=26&type=section&id=Item%203.%20Quantitative%20and%20Qualitative%20Disclosures%20About%20Market%20Risk) The company reports that there have been **no material changes** in its market risk exposures for the quarter ended December 31, 2023, compared to the information provided in its Annual Report on Form 10-K for the fiscal year ended September 30, 2023 - Information about market risks for the period ended December 31, 2023, **does not differ materially** from the disclosures in the 2023 10-K[42](index=42&type=chunk) [Item 4. Controls and Procedures](index=26&type=section&id=Item%204.%20Controls%20and%20Procedures) Based on an evaluation as of December 31, 2023, the company's principal executive officer and principal financial officer concluded that **disclosure controls and procedures were effective**, with **no material changes in internal control over financial reporting** during the quarter - Management, including the CEO and CFO, concluded that the company's **disclosure controls and procedures were effective** as of December 31, 2023[147](index=147&type=chunk) - **No changes in internal control over financial reporting** occurred during the quarter that have materially affected, or are reasonably likely to materially affect, internal controls[147](index=147&type=chunk) [Part II. Other Information](index=27&type=section&id=Part%20II.%20Other%20Information) [Item 2. Unregistered Sales of Equity Securities and Use of Proceeds](index=27&type=section&id=Item%202.%20Unregistered%20Sales%20of%20Equity%20Securities%20and%20Use%20of%20Proceeds) This section details the company's repurchases of its common stock during the first quarter of fiscal 2024, with Cabot repurchasing a total of **260,094 shares** under its publicly announced plan, which does not have a set expiration date Issuer Purchases of Equity Securities (Q1 FY2024) | Period | Total Shares Purchased | Average Price Paid per Share | | :--- | :--- | :--- | | Oct 2023 | 0 | $ - | | Nov 2023 | 191,954 | $76.74 | | Dec 2023 | 68,140 | $77.33 | | **Total** | **260,094** | **N/A** | - The Board of Directors authorized a share repurchase program on July 13, 2018, which does not have a set expiration date. As of December 31, 2023, **2,724,876 shares remained available for repurchase** under this plan[44](index=44&type=chunk)[144](index=144&type=chunk) [Item 6. Exhibits](index=27&type=section&id=Item%206.%20Exhibits) This section lists the exhibits filed as part of the quarterly report, including the company's certificate of incorporation, by-laws, and **certifications from the Principal Executive Officer (31.1) and Principal Financial Officer (31.2)** as required by SEC rules - The report includes several exhibits, such as **certifications from the Principal Executive Officer (31.1) and Principal Financial Officer (31.2)** as required by the Exchange Act, and XBRL data files[121](index=121&type=chunk)
Cabot (CBT) - 2024 Q1 - Earnings Call Transcript
2024-02-06 18:58
Cabot Corporation (NYSE:CBT) Q1 2024 Earnings Conference Call February 6, 2024 8:00 AM ET Company Participants Steve Delahunt - Vice President, Treasurer and Investor Relations Sean Keohane - Chief Executive Officer and President Erica McLaughlin - Executive Vice President and Chief Financial Officer Conference Call Participants David Huang - Deutsche Bank Laurence Alexander - Jefferies Chris Kapsch - Loop Capital Markets James Cannon - UBS John Roberts - Mizuho Operator Good day, and thank you for standing ...